Continucare Corporation Named Emerging Growth Company Of The Year By ACG-South Florida
Continucare Corporation (NYSE Amex:CNU) today announced that it was
named the Emerging Growth Company of the Year by the South Florida
Chapter of the Association for Corporate Growth (ACG-South Florida).
Continucare Corporation (NYSE Amex:CNU) today announced that it was named the Emerging Growth Company of the Year by the South Florida Chapter of the Association for Corporate Growth (ACG-South Florida). The award recognizes South Florida’s outstanding companies that are building and leading dynamic, growing businesses. “We are honored to have received this prestigious award,” said Richard C. Pfenniger, Jr., Continucare’s Chairman and Chief Executive Officer. “This accomplishment is a reflection of the quality people that comprise Continucare, our outstanding leadership team and the culture we are creating.” About ACG Founded in 1954, the Association for Corporate Growth (ACG) is the premier global association for professionals involved in corporate growth, corporate development and mergers and acquisitions. Today ACG stands at over 13,000 members from corporations, private equity, finance and professional service firms representing Fortune 500, Fortune 1000, FTSE 100 and mid-market companies in 54 chapters in North America and Europe. Leaders in corporations, private equity, finance and professional service firms focused on building value in their organizations belong to ACG. About Continucare Corporation Continucare provides primary care physician services on an outpatient basis through a network of medical facilities and independent physician affiliates (IPAs) in the State of Florida. Continucare has 18 medical offices equipped with state-of-the-practice technology and staffed with experienced physicians and a comprehensive support staff. In addition, Continucare provides health practice management services to IPAs who practice primary care medicine in South Florida. Continucare assists these physicians with medical utilization and pharmacy management and specialist network development, freeing them to devote more time to patient care. Also, through its subsidiary, Seredor Corporation, Continucare operates sleep diagnostic centers in seven states. For more information on Continucare please visit www.continucare.com, and for more information on Seredor please visit www.Seredor.com. Except for historical matters contained herein, statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.Investors and others are cautioned that forward-looking statements are subject to risks and uncertainties that may affect our business and prospects and cause our actual results to differ materially from those set forth in the forward-looking statements including the following: our operations are dependent on three health maintenance organizations; under our most important contracts we are responsible for the cost of medical services to our patients in return for a capitated fee; our revenues will be affected by the Medicare Risk Adjustment program; if we are unable to manage medical benefits expense effectively, our profitability will likely be reduced; a failure to estimate incurred but not reported medical benefits expense accurately will affect our profitability; we compete with many health care providers for patients and HMO affiliations; we may not be able to successfully recruit or retain existing relationships with qualified physicians and medical professionals; our business exposes us to the risk of medical malpractice lawsuits; we primarily operate in Florida; a significant portion of our voting power is concentrated; we are dependent on our executive officers and other key employees; we depend on the management information systems of our affiliated HMOs; we depend on our information processing systems; the volatility of our stock price; a failure to successfully implement our business strategy could materially and adversely affect our operations and growth opportunities; our intangible assets represent a substantial portion of our total assets; competition for acquisition targets and acquisition financing and other factors may impede our ability to acquire other businesses and may inhibit our growth; our acquisitions could result in integration difficulties, unexpected expenses, diversion of management’s attention and other negative consequences; enacted health care reform could adversely affect our business; a decrease to our Medicare capitation payments may have a material adverse effect on our results of operations, financial position and cash flows; we are subject to government regulation; the health care industry is subject to continued scrutiny; our insurance coverage may not be adequate, and rising insurance premiums could negatively affect our profitability; deficit spending and economic downturns could negatively impact our results of operations; and many factors that increase health care costs are largely beyond our ability to control.These and other applicable risks, cautionary statements and factors that could cause actual results to differ from our forward-looking statements are included in our most recent annual report on Form 10-K and other filings with the SEC and we urge you to read those documents.We undertake no obligation to update or revise these forward-looking statements to reflect events or circumstances after the date hereof except as required by law.